Treatment of post-transplantation lymphoproliferative disorders after kidney transplant with rituximab and conversion to m-TOR inhibitor. Colomb Med [Internet]. 2016 Dec. 30 [cited 2026 Jan. 2];47(4):196-202. Available from: https://colombiamedica.univalle.edu.co/index.php/comedica/article/view/1989